Exploring the Long-Term Safety of Asenapine in Adults With Schizophrenia in a Double-Blind, Fixed-Dose, Extension Study
Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s130211
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2017
Authors
Publisher
Informa UK Limited